Page last updated: 2024-08-24

2,2'-dithiodiethanesulfonic acid and Neoplasms

2,2'-dithiodiethanesulfonic acid has been researched along with Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hausheer, F; Murphy, M; Pendyala, L; Schwartz, G; Smith, P; Zdanowicz, J1
Galanski, M; Jakupec, MA; Keppler, BK1
Boven, E; Giaccone, G; Ruijter, R; van der Vijgh, WJ; van Groeningen, CJ; Verschraagen, M; Westerman, M; Zegers, I1
Graham, MI; Shaw, IC1

Reviews

2 review(s) available for 2,2'-dithiodiethanesulfonic acid and Neoplasms

ArticleYear
The effect of cytoprotective agents in platinum anticancer therapy.
    Metal ions in biological systems, 2004, Volume: 42

    Topics: Amifostine; Antineoplastic Agents; Cell Survival; Glutathione; Humans; Mesna; Neoplasms; Platinum Compounds; Protective Agents; Thioctic Acid; Vitamin E

2004
Mesna--a short review.
    Cancer treatment reviews, 1987, Volume: 14, Issue:2

    Topics: Cystitis; Expectorants; Humans; Mercaptoethanol; Mesna; Neoplasms

1987

Trials

1 trial(s) available for 2,2'-dithiodiethanesulfonic acid and Neoplasms

ArticleYear
Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule.
    British journal of cancer, 2005, May-09, Volume: 92, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dehydration; Female; Humans; Kidney Diseases; Male; Mesna; Middle Aged; Neoplasms

2005

Other Studies

1 other study(ies) available for 2,2'-dithiodiethanesulfonic acid and Neoplasms

ArticleYear
Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.
    Cancer chemotherapy and pharmacology, 2003, Volume: 51, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cisplatin; Cysteine; Disulfides; Glutathione; Half-Life; Humans; Infusions, Intravenous; Kinetics; Mesna; Neoplasms; Paclitaxel; Sulfhydryl Compounds

2003